Patent · US Active

IL-11 antibodies

US11084874B2 · kind B2 · utility

0Cited by
0References
6Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 13, 2019
Grant dateAug 10, 2021
Priority date—
Expiry dateJun 13, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are antigen-binding molecules capable of binding to IL-11, and methods of medical treatment and prophylaxis using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.